Kurs & Likviditet
Prenumeration
Beskrivning
Land | Finland |
---|---|
Lista | First North Finland |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
Herantis Pharma Plc | Company release | 4 July 2024 at 15:30 EEST
Herantis Pharma Oyj: Managers' Transactions – Henri Huttunen
Herantis Pharma Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Henri Huttunen
Position: Other senior manager
Issuer: Herantis Pharma Oyj
LEI: 743700W4CQVYAT3WKK38
Notification type: INITIAL NOTIFICATION
Reference number: 69394/4/4
____________________________________________
Transaction date: 2024-07-04
Outside a trading venue
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Name of the instrument: 2024 option rights in Herantis Pharma Plc
Nature of transaction: ACCEPTANCE OF A STOCK OPTION
Transaction details
(1): Volume: 100000 Unit price: 0 EUR
Aggregated transactions (1):
Volume: 100000 Volume weighted average price: 0 EUR ____________________________________________
For more information, please contact:
Tone Kvåle, CFO
Tel: +47 915 19576
Email: ir@herantis.com
Certified Advisor:
UB Corporate Finance Oy, Finland: +358 9 25 380 225
Company website: www.herantis.com